MHRA announces proposals to improve access to world’s best medical devices for patients and to boost economic growth in Britain’s med tech sector

The microscopic bacteria living in women’s bodies could be a powerful tool for personalised, non-invasive treatment and earlier diagnosis.

The MHRA is consulting with UK stakeholders to gather feedback and comments on a revised international guideline, M4Q(R2).

In this new role, Professor George will lead the Agency’s science strategy and will oversee the MHRA’s scientific, research and innovation activities.

Use this form to transfer a product licence, also known as a marketing authorisation, to a different owner.

Application Form to be completed by an Applicant and sent to the MHRA requesting consideration of an award of a Decentralised Manufacture (DM) Designation.

Summary of the latest safety advice for medicines and medical device users